[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Checkit Fundamental Research Analyst posts on X about goldman sachs, $152b, banking, $101b the most. They currently have XXX followers and XXX posts still getting attention that total X engagements in the last XX hours.
Social category influence stocks finance exchanges automotive brands
Social topic influence goldman sachs #521, $152b, banking, $101b, $14b, $465m, debt, $788m, $35b, $37b
Top assets mentioned Goldman Sachs (GS) Johnson & Johnson (JNJ) Joby Aviation, Inc. (JOBY)
Top posts by engagements in the last XX hours
"Goldman Sachs Q3 2025 Earnings Call #SmartEaringCall S1: Financial & Operational Highlights Net revenues $15.2B; EPS $XXXXX. ROE XXXX% ROTCE 15.2%. Global Banking & Markets: $10.1B revenue. Advisory revenue $1.4B (+60% YoY); Equity underwriting $465M (+21%); Debt underwriting $788M (+30%). FICC revenue $3.5B (+17%); Equities $3.7B; Equities financing record $1.7B (+33%). Asset & Wealth Mgmt: $4.4B revenue; management fees record $2.9B (+12%); AUM record $3.5T. Alternatives AUM $374B; fundraising record $33B. NII $3.9B; loan book $222B; credit loss provisions $339M. Operating expenses $9.5B;"
X Link @CheckIt30330637 2025-10-15T00:21Z XXX followers, XX engagements
"Goldman Sachs Q3 Earnings Preview Goldman Sachs is expected to release its fiscal Q3 2025 earnings report on October XX 2025. Analysts forecast earnings per share (EPS) of $XXXXX representing a XXXX% year-over-year increase and revenue of $XXXXX billion up XXXX% from the prior year. The strong earnings outlook is largely driven by a recovery in investment banking and trading operations with a particular boost from the rebound in mergers and acquisitions (M&A) activity which has become a key growth driver. Source: Checkit Analytics"
X Link @CheckIt30330637 2025-10-13T20:08Z XXX followers, XX engagements
"#Johnson&Johnson Q3 Earnings Preview Johnson & Johnson is scheduled to release its fiscal Q3 2025 earnings before market open on October XX 2025. Analysts expect earnings per share (EPS) of $XXXX up XXXX% year-over-year and revenue of $XXXXX billion representing XXX% growth from the prior year. Key investor focus areas include how the company manages biosimilar competition to its blockbuster drug Stelara as well as performance across its MedTech and innovative pharmaceutical divisions. Source: Checkit Analytics"
X Link @CheckIt30330637 2025-10-13T20:07Z XXX followers, XX engagements
"🚀 #Microvast (NASDAQ: $MVST) Surges on Unusual Options Activity & Institutional Buying 📈 Stock Jump: $MVST soared +21.1% to $XXXX (high $5.40) on Oct XX 2025 marking a strong rebound from its 52-week low of $XXXX. 🔥 Key Catalyst: Unusually high call-option volume (12681 contracts +113%) signaling strong bullish sentiment. 📊 Trading Volume: XXX XXXX million shares traded vs. XXX million daily average. 🏦 Institutional Buying: JPMorgan 680832.5% XXX M shares ($11.3 M) Geode Capital XXX% XXX M shares ($16.8 M) Millennium XXX% XXX M shares BofA XXX% XXX M shares 📈 Analyst Upgrade: Zacks"
X Link @CheckIt30330637 2025-10-13T20:19Z XXX followers, XXX engagements
"#Jobys valuation bubble keeps inflating its now worth more than #Rivn and about the same as #Nio. What an irrational market ⚠ #Caution a $JOBY plunge coming soon again. $joby is just still a pre-revenue prototype company but valued at over XX times the market cap of $EH which already generates $XXX million in annual revenue. #ShortJOBY"
X Link @CheckIt30330637 2025-10-14T23:59Z XXX followers, XXX engagements